StonvexLoading…
StonvexCore line items from SENS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.26M | $22.47M | $22.39M | $16.39M |
Operating Income | $-68.34M | $-74.84M | $-75.60M | $-68.63M |
Net Income | $-69.11M | $-78.62M | $-60.39M | $142.12M |
EPS (Diluted) | $-1.66 | $-2.50 | $-0.11 | $-0.11 |
Total Assets | $126.27M | $100.44M | $138.22M | $177.67M |
Total Liabilities | $65.22M | $79.34M | $64.77M | $142.59M |
Cash & Equivalents | $40.23M | $74.60M | $75.71M | $35.79M |
Free Cash Flow OCF − CapEx | $-60.24M | $-62.70M | $-70.51M | $-66.62M |
Shares Outstanding | 41.27M | 29.77M | 530.36M | 479.64M |